The scope for this technology appraisal included lutetium-177 dotatate (177Lu-dotatate). NICE cannot release any recommendations on 177Lu-dotatate until it has a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use. A separate document with the committee’s recommendations will be released when this opinion is received. Information about this separate document can be found on the NICE website.